Novartis and Roche ordered to pay €30.9 million cartel fine

The Turkish Competition Authority has become the latest enforcer to fine pharmaceutical companies Novartis and Roche for colluding to exaggerate a drug's potential side effects to encourage users to purchase a more expensive one.


Get unlimited access to all Global Competition Review content